H. Nieuwenhuis

发表

A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group.

F. Rosendaal, J. van der Meer, H. M. van den Berg, 1993, Blood.

Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis.

J. Sixma, C. Frijns, L. Kappelle, 1997, Stroke.

Combination of a Normal D-Dimer Concentration and a Non-High Pretest Clinical Probability Score Is a Safe Strategy to Exclude Deep Venous Thrombosis

M. Pruijm, J. Kelder, H. Nieuwenhuis, 2003, Circulation.

Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients.

H. Nieuwenhuis, R. Schutgens, D. Biesma, 2002, The American journal of medicine.

Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin).

J. Sixma, P. D. de Groot, H. Gralnick, 1994, Blood.

Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies

J. Sixma, H. Schuurman, H. Nieuwenhuis, 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery.

J. Sixma, H. Nieuwenhuis, M. Metzelaar, 1993, The Journal of laboratory and clinical medicine.

Increased Thromboxane Biosynthesis in Patients With Acute Cerebral Ischemia

P. Koudstaal, J. Sixma, C. Patrono, 1993, Stroke.

Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia

J. Sixma, J. Akkerman, H. Nieuwenhuis, 1985, Nature.

Platelet Adhesion to Collagen

J. Sixma, P. D. de Groot, H. Nieuwenhuis, 1995, Thrombosis and Haemostasis.

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.

P. D. de Groot, T. Lambert, E. Mauser-Bunschoten, 2002, Blood.

Factor V Leiden in central venous catheter‐associated thrombosis

L. Verdonck, H. Nieuwenhuis, M. Roest, 2002, British journal of haematology.

Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation

P. D. de Groot, J. van der Meer, F. Leebeek, 2002, Hepatology.

Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.

P. D. de Groot, H. Janssen, F. Leebeek, 2001, Gastroenterology.

Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor

P. D. de Groot, H. Nieuwenhuis, T. Lisman, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux

P. D. de Groot, M. Levi, H. Nieuwenhuis, 2003, Journal of thrombosis and haemostasis : JTH.

Low molecular weight heparin is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism

R. Snijder, F. Verzijlbergen, H. Nieuwenhuis, 2004 .

Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.

R. Snijder, F. Verzijlbergen, H. Nieuwenhuis, 2004, The Journal of laboratory and clinical medicine.

Comparing Subcutaneous Danaparoid with Intravenous Unfractionated Heparin for the Treatment of Venous Thromboembolism

J. Sixma, J. Wester, H. D. de Valk, 1995, Annals of Internal Medicine.

Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading.

Kjell, J. Sixma, H. Nieuwenhuis, 1986, Blood.

Agents interfering with the platelet-vessel wall interaction

J. Sixma, H. Nieuwenhuis, 1984, Pharmaceutisch Weekblad.

Biochemical Characterization of PECAM-1 (CD31 Antigen) on Human Platelets

J. Sixma, H. Nieuwenhuis, M. Metzelaar, 1991, Thrombosis and Haemostasis.

The Origin of P-selectin as a Circulating Plasma Protein

J. Sixma, C. Frijns, H. Nieuwenhuis, 1997, Thrombosis and Haemostasis.

Recombinant factor VIIa reverses the anticoagulant and profibrinolytic effect of the synthetic pentasaccharide ORG31540/SR90107A in vitro

H. Nieuwenhuis, T. Lisman, J. Adelmeijer, 2001 .

Low-dose immune tolerance induction in hemophilia A patients with inhibitors.

H. M. van den Berg, G. Roosendaal, E. Mauser-Bunschoten, 1995, Blood.

Risk Factors for Bleeding during Treatment of Acute Venous Thromboembolism

J. Sixma, Y. van der Graaf, H. D. de Valk, 1996, Thrombosis and Haemostasis.

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies.

P. D. de Groot, M. van Vliet, R. Derksen, 1992, American journal of obstetrics and gynecology.

Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation.

J. V. van Oosterhout, H. Nieuwenhuis, E. Rozemuller, 1987, Blood.

Factor V Leiden, Antiphospholipid Antibodies and Thrombosis in Systemic Lupus Erythematosus

P. D. de Groot, R. Derksen, H. Nieuwenhuis, 1996, Thrombosis and Haemostasis.

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells

H. Nieuwenhuis, M. Tilanus, E. Petersen, 1998, Bone Marrow Transplantation.

How to treat women with antiphospholipid antibodies in pregnancy?

R. Derksen, H. Nieuwenhuis, G. Christiaens, 2001, Annals of the rheumatic diseases.

L antibodies in pregnancy ? How to treat women with antiphospholipid

R. Derksen, H. Nieuwenhuis, P. Groot, 2000 .

Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage

W. Ouwehand, H. Nieuwenhuis, D. Roos, 1990, Transfusion.

Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.

J. Sixma, P. D. de Groot, H. Nieuwenhuis, 1994, The Journal of clinical investigation.

Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects.

J. Sixma, P. D. de Groot, J. van Gijn, 1987, Thrombosis research.

Storage-pool-Erkrankungen

H. Nieuwenhuis, 1999 .

Myeloid sarcoma presenting as a recurrent, multifocal nerve root entrapment syndrome

G. Rutten, K. Han, H. Nieuwenhuis, 2008, Journal of Neuro-Oncology.

Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation

H. Nieuwenhuis, E. Rozemuller, J. Sixma, 1987 .

The 33-kDa Platelet α-granule Membrane Protein (GMP-33) Is an N-terminal Proteolytic Fragment of Thrombospondin

J. Sixma, H. Nieuwenhuis, T. Vink, 2001, Thrombosis and Haemostasis.

Identification of a 33-Kd protein associated with the alpha-granule membrane (GMP-33) that is expressed on the surface of activated platelets.

J. Sixma, H. Nieuwenhuis, H. Heijnen, 1992, Blood.

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.

P. D. de Groot, H. Nieuwenhuis, T. Lisman, 2003, Blood.

Platelet Adhesion to Collagen and Endothelial Cell Matrix Under Flow Conditions Is Not Dependent on Platelet Glycoprotein IV

J. Sixma, H. Nieuwenhuis, B. Kehrel, 1994 .

Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV.

J. Sixma, P. D. de Groot, H. Nieuwenhuis, 1994, Blood.

New irons in the fire

H. Nieuwenhuis, J. Sixma, 1996, The Lancet.

The Defective Down Regulation of Fibrinolysis in Haemophilia A Can Be Restored by Increasing the TAFI Plasma Concentration

H. Nieuwenhuis, J. Meijers, T. Lisman, 2001, Thrombosis and Haemostasis.

Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor

I. Nováková, H. Nieuwenhuis, I. Novàkovà, 1997, European journal of haematology.

Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.

H. Nieuwenhuis, H. Lokhorst, G. D. de Gast, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft.

H. Nieuwenhuis, H. Lokhorst, G. D. de Gast, 1994, Blood.

Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.

H. Nieuwenhuis, A. Dekker, L. Verdonck, 1990, Haematology and blood transfusion.

Long‐term outcome of individualized prophylactic treatment of children with severe haemophilia

F. Beek, K. Fischer, J. G. van der Bom, 2001, British journal of haematology.

Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft [see comments]

H. Nieuwenhuis, H. Lokhorst, A. Dekker, 1994 .

Graft-versus-myeloma effect in two cases

H. Nieuwenhuis, H. Lokhorst, A. Dekker, 1996, The Lancet.

1-Desamino-8-D-arginine vasopressin (desmopressin) shortens the bleeding time in storage pool deficiency.

J. Sixma, H. Nieuwenhuis, 1988, Annals of internal medicine.

ATP‐ADP compartmentation in storage pool deficient platelets: correlation between granule‐bound ADP and the bleeding time

J. Sixma, J. Akkerman, H. Nieuwenhuis, 1983, British journal of haematology.

Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients.

J. Sixma, J. Akkerman, H. Nieuwenhuis, 1987, Blood.

Platelet adhesion to collagen type IV under flow conditions.

J. Sixma, P. D. de Groot, P. Slootweg, 1996, Blood.

Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide.

J. Sixma, P. D. de Groot, A. Uzan, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Detection of platelet activation using activation specific monoclonal antibodies.

J. Sixma, H. Nieuwenhuis, M. Metzelaar, 1990, Blood cells.

Antibodies to platelets in patients with anti-phospholipid antibodies.

P. D. de Groot, R. Derksen, H. Nieuwenhuis, 1991, Blood.

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

J. Sixma, H. Nieuwenhuis, J. Albada, 1989, Circulation.

Clinical Course of Factor VIII Inhibitors Developed after Exposure to a Pasteurised Dutch Concentrate Compared to Classic Inhibitors in Hemophilia A

F. Rosendaal, H. M. van den Berg, G. Roosendaal, 1994, Thrombosis and Haemostasis.

MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents.

P. Sonneveld, J. Cornelissen, H. Nieuwenhuis, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation

H. Nieuwenhuis, H. Lokhorst, A. Dekker, 2004, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation

H. Nieuwenhuis, A. Dekker, G. Gast, 1991 .

Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation.

H. Nieuwenhuis, G. D. de Gast, A. Dekker, 1991, Blood.

Thrombocytopenia and the neglected megakaryocyte.

J. Sixma, H. Nieuwenhuis, 1992, The New England journal of medicine.

CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells.

M J Metzelaar, H C Clevers, J J Sixma, 1991, The Journal of biological chemistry.

Differentiation of patients with subtype IIb‐like von Willebrand's disease by means of perfusion experiments with reconstituted blood

J. Sixma, H. Nieuwenhuis, K. Sakariassen, 1985, British journal of haematology.

Risk factors for thrombosis in lupus patients.

P. D. de Groot, R. Derksen, H. Nieuwenhuis, 1989, Annals of the rheumatic diseases.

Identity of Pltgp40 and lysomal integral membrane protein-CD63.

H. Nieuwenhuis, M. Metzelaar, 1991, Blood.

Comparison of Platelet Counts in First and Second Newborns of Mothers With Immune Thrombocytopenic Purpura

J. Bussel, H. Nieuwenhuis, G. Christiaens, 1997, Obstetrics and gynecology.

Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.

L. Verdonck, H. Nieuwenhuis, H. Lokhorst, 1997, Blood.

Relationship between graft‐versus‐host disease and graft‐versus‐leukaemia in partial T cell‐depleted bone marrow transplantation

L. Verdonck, H. Nieuwenhuis, R. Fijnheer, 2001, British journal of haematology.

Idiopathic thrombocytopenic purpura in pregnancy: A randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count

I. van der Tweel, H. Nieuwenhuis, H K Nieuwenhuis, 1991, British journal of obstetrics and gynaecology.

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

P. Sonneveld, G. Veth, H. Nieuwenhuis, 1999, Bone Marrow Transplantation.

Idiopathic thrombocytopenic purpura in pregnancy: A randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count

W. Ouwehand, A. Borne, H. Nieuwenhuis, 1990 .

The FcγRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation

L. Verdonck, H. Nieuwenhuis, R. Fijnheer, 2005 .

The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.

L. Verdonck, H. Nieuwenhuis, J. V. D. van de Winkel, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission.

H. Nieuwenhuis, H. Lokhorst, G. D. de Gast, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin.

J. Sixma, J. Banga, H. Nieuwenhuis, 1991, Blood.

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

P. D. de Groot, R. Derksen, H. Nieuwenhuis, 1993, Annals of the rheumatic diseases.

[Idiopathic thrombocytopenic purpura in pregnancy].

W. Ouwehand, H. Nieuwenhuis, G. Christiaens, 1987, Nederlandsch tijdschrift voor geneeskunde.

Platelet adhesion to cyanogen-bromide fragments of collagen alpha 1(I) under flow conditions.

J. Sixma, P. D. de Groot, H. Gralnick, 1993, Blood.

The usefulness of five d‐dimer assays in the exclusion of deep venous thrombosis

H. Nieuwenhuis, R. Schutgens, F. Haas, 2003, Journal of thrombosis and haemostasis : JTH.

ADHESION OF BLOOD PLATELETS TO THE EXTRACELLULAR MATRIX OF CULTURED CELLS IN WHICH COLLAGEN SYNTHESIS IS IMPAIRED OR INDUCED

J. Sixma, H. D. de Boer, H. Nieuwenhuis, 1987, Thrombosis and Haemostasis.

Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid org 10172

J. Sixma, H. Nieuwenhuis, H. Karel Nieuwenhuis, 1986, Cancer.

Responses of Platelets to Strains of Streptococcus sanguis: Findings in Healthy Subjects, Bernard-Soulier, Glanzmann’s, and Collagen-Unresponsive Patients

J. Sixma, M. Herzberg, H. Nieuwenhuis, 1987, Thrombosis and Haemostasis.

Recombinant factor VIIa improves clot formation but not tafi-mediated downregulation of fibrinolysis in patients with cirrhosis and during liver transplantation.

J. Meer, F. Leebeek, K. Meijer, 2001 .